文献速递慢性肾脏病肾血管病与高血压

年轻CKD成人血压与心血管事件及肾功能下降的关联

BP in Young Adults with CKD and Associations with Cardiovascular Events and Decline in Kidney Function.
PubMed 文献 · J Am Soc Nephrol · 2021-03-10

本研究基于CRIC队列中317名21-40岁轻中度CKD年轻成人,观察基线收缩压与心血管事件及CKD进展的关系。中位随访11.3年和4.1年期间,分别发生52例心血管事件和161例CKD进展。基线收缩压≥130 mmHg较<120 mmHg与心血管事件或死亡风险(HR 2.13)及CKD进展风险(HR 1.68)显著相关。

要点

  • 年轻CKD患者收缩压≥130 mmHg与心血管事件或死亡风险增加相关(HR 2.13)。
  • 收缩压≥130 mmHg与CKD进展风险增加相关(HR 1.68)。
  • 需专门针对年轻CKD患者开展血压管理临床试验以确定目标和策略。

核心结论

  • 在年轻CKD成人中,较高的收缩压与心血管事件和CKD进展风险增加显著相关。

研究设计与样本

  • 观察性研究,纳入CRIC研究中317名21-40岁轻中度CKD年轻成人。

主要发现

  • 中位随访11.3年期间发生52例心血管事件,中位随访4.1年期间161例发生CKD进展。
  • 基线收缩压≥130 mmHg者心力衰竭发生率3%/年,CKD进展率20%/年,死亡率2%/年。
  • 完全调整模型中,基线收缩压≥130 mmHg较<120 mmHg与心血管事件或死亡相关(HR 2.13;95%CI 1.05-4.32)。
  • 基线收缩压≥130 mmHg较<120 mmHg与CKD进展相关(HR 1.68;95%CI 1.10-2.58)。

关键数值与推荐

  • 收缩压暴露按连续变量(每增加10 mmHg)及分类(<120、120-129、≥130 mmHg)评估。
  • 主要结局为心血管事件(心力衰竭、心肌梗死、卒中或全因死亡)和CKD进展(eGFR下降50%或ESKD)。

临床怎么用

  • 年轻CKD患者应关注收缩压水平,≥130 mmHg提示心血管和肾脏不良结局风险增高。
  • 目前缺乏针对年轻CKD人群的血压管理随机试验证据,需个体化评估降压策略。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: BP is an important modifiable risk factor for cardiovascular events and CKD progression in middle-aged or older adults with CKD. However, studies describing the relationship between BP with outcomes in young adults with CKD are limited. METHODS: In an observational study, we focused on 317 young adults (aged 21-40 years) with mild to moderate CKD enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study. Exposures included baseline systolic BP evaluated continuously (per 10 mm Hg increase) and in categories (<120, 120-129, and ≥130 mm Hg). Primary outcomes included cardiovascular events (heart failure, myocardial infarction, stroke, or all-cause death) and CKD progression (50% decline of eGFR or ESKD). We used Cox proportional hazard models to test associations between baseline systolic BP with cardiovascular events and CKD progression. RESULTS: Cardiovascular events occurred in 52 participants and 161 had CKD progression during median follow-up times of 11.3 years and 4.1 years, respectively. Among those with baseline systolic BP ≥130 mm Hg, 3%/yr developed heart failure, 20%/yr had CKD progression, and 2%/yr died. In fully adjusted models, baseline systolic BP ≥130 mm Hg (versus systolic BP<120 mm Hg) was significantly associated with cardiovascular events or death (hazard ratio [HR], 2.13; 95% confidence interval [95% CI], 1.05 to 4.32) and CKD progression (HR, 1.68; 95% CI, 1.10 to 2.58). CONCLUSIONS: Among young adults with CKD, higher systolic BP is significantly associated with a greater risk of cardiovascular events and CKD progression. Trials of BP management are needed to test targets and treatment strategies specifically in young adults with CKD.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Kula AJ, Prince DK, Flynn JT, et al. BP in Young Adults with CKD and Associations with Cardiovascular Events and Decline in Kidney Function. J Am Soc Nephrol. 2021. PMID: 33692088. doi:10.1681/ASN.2020081156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。